Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Forodesine Hydrochloride in Advanced T-cell Leukemia
2004-004286-15Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of forodesine in T-cell prolymphocytic leukemia (T-PLL), sponsored by BioCryst Pharmaceuticals, Inc.. Started Feb 2005; status: completed.
02
Drugs
forodesine
03
Conditions
T-cell prolymphocytic leukemia (T-PLL)
Beyond the preview
Go deeper on 2004-004286-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004286-15.